查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087350

全球即時血液學診斷市場：機會與策略展望（至2035年）

Point Of Care Hematology Diagnostics Global Market Opportunities And Strategies To 2035
出版日期: | 出版商: The Business Research Company | 英文 381 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

2020 年全球即時血液診斷市場價值 19.475 億美元，預計到 2025 年將以超過 8.00% 的複合年成長率成長。

即時檢驗（POC）是指在病人就診的診所或附近，使用小型攜帶式分析儀而非在中心檢查室進行的血液檢測。 POC血液檢測的主要目的是透過立即（通常在幾分鐘內）提供檢測結果，從而實現快速的臨床決策。這使得醫護人員能夠快速診斷貧血、感染疾病和其他血液疾病等病症，及時啟動治療，並即時監測患者的病情。

即時血液學診斷市場包括營業單位、自營商和夥伴關係等實體銷售的即時血液學診斷產品。這些產品包括攜帶式分析儀、可攜式儀器、試劑盒和試劑，用於測量關鍵血液學指標，例如紅血球計數、白血球計數、血紅蛋白濃度、血球比容、血小板計數和凝血參數。

提高對貧血和血液相關疾病的認知，並擴大篩檢項目

從歷史上看，即時血液診斷市場的發展主要得益於人們對貧血和血液相關疾病的認知不斷提高，以及篩檢計畫的擴展。這些宣傳和篩檢計畫是旨在普及相關知識、透過系統檢測對個體進行篩檢的公共衛生舉措，從而實現早期發現、診斷和治療。針對貧血和血液相關疾病的宣傳和篩檢項目，透過促進早期發現、提高檢測頻率，以及推動對快速、便捷和分散式血液檢測解決方案的需求，正在擴大對即時診斷的需求。例如，根據印度衛生和家庭福利部（MoHFW）2025年8月發布的數據，印度醫學研究理事會（ICMR）——一家領先的印度醫療機構——正在驗證30種鐮狀檢測方法和5種非快速診斷檢測方法在鐮狀細胞貧血（SCD）篩檢的有效性，這是國家根除鐮狀細胞貧血症計劃的一部分。截至2025年7月，篩檢超過6,000名原住民在17個原住民佔多數的邦檢驗。因此，在這段歷史時期，即時血液學診斷市場的發展受到多種趨勢的推動，例如人們對貧血和血液相關疾病的認知不斷提高，以及篩檢計畫的擴展。

生物技術、基因組學和精準醫療

在即時血液學診斷市場中，領導企業正日益整合生物技術、基因組學和精準醫療方法，以提高分散式醫療機構中血液檢測的準確性、速度和臨床相關性。這一趨勢著重於利用遺傳易感性、分子層面血液特徵、免疫反應模式和患者特異性血液學變異等生物學訊息，改進血液常規檢查(CBC) 及相關參數的解讀。透過將微流體技術、人工智慧驅動的血液形態學分析和數位病理學等先進診斷技術與精準醫療框架相結合，企業可以超越傳統的靜態血球計數，獲得更具情境性和患者特異性的血液學資訊。這種方法有助於更早發現疾病，更好地監測貧血、感染疾病和血液疾病等狀況，並在臨床環境中做出更恰當的治療決策。

全球即時血液診斷市場高度分散，許多小規模企業參與其中。截至2024年，前十名的競爭對手僅佔24.27%的市佔率。

目錄

第1章：執行摘要

第2章 目錄

第3章表格一覽

第4章：圖表一覽

第5章：報告結構

第6章 市場特徵

  • 市場的一般定義
  • 概述
  • 即時血液學診斷市場：定義與細分
  • 按類型分類的市場細分（血液常規檢查、血液凝固檢驗、血紅素測試、貧血診斷等）
  • 按處方藥類型（處方藥和非處方藥）進行市場細分
  • 按最終用戶分類的市場細分（診斷中心、醫院、血庫、輸血中心和其他最終用戶）

第7章：即時血液診斷市場：主要產品與服務概述

  • 全球即時血液學診斷市場：吸引力評分及分析
    • 市場吸引力框架概述
    • 定量評分調查方法
    • 市場吸引力評分的計算與解讀
    • 因素特定評估
    • 戰略洞察與建議

第8章：即時血液診斷市場及供應鏈分析

  • 供應鏈與生態系概述
  • 參考資料
    • 主要原料及供應商清單
  • 製造商
    • 製造商（供應商）名單
  • 分配
    • 主要經銷商和通路合作夥伴名單
  • 最終用戶
    • 主要最終用戶列表

第9章：主要市場趨勢

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧和自主智慧
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料和網路安全
    • 工業4.0和智慧製造
  • 主要趨勢
    • 人工智慧驅動的可攜式系統正在革新快速血液分析，從而加速臨床決策速度。
    • 診所以小型血液檢測設備的進步，使得快速、分散的血液檢測成為可能。
    • 整合多模態桌上型分析儀可實現快速、分散的血液檢測和加速臨床決策。
    • 人工智慧驅動的盒式血液分析技術取得了進步，可實現快速、準確的現場診斷。
    • 新一代小容量血液檢測將徹底改變診斷領域。

第10章：即時血液學診斷市場：成長分析與策略分析框架

  • 全球即時血液學診斷市場：PESTEL 分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術的
    • 環境因素
    • 合法的
  • 最終用戶（B2B）分析
    • 診斷中心
    • 醫院
    • 血庫
    • 輸血中心
    • 其他最終用戶

第11章：全球即時血液診斷市場規模及成長分析

  • 2020-2025年市場成長表現
    • 市場促進因素，2020-2025 年
    • 2020-2025年市場限制因素
  • 市場成長預測，2025-2030年，2035年
  • 預測的成長要素和促進因素
    • 定量成長要素
    • 促進因素
    • 抑制因子

第12章：全球即時血液診斷市場總潛在市場規模（TAM）分析

  • 總潛在市場（TAM）的定義與範圍
  • 調查方法和先決條件
    • 潛在市場總量：即時血液學診斷市場 - B2B
    • TAM比較分析

第13章 全球即時血液學診斷：市場細分

  • 按類型
  • 按處方類型
  • 最終用戶
  • 按類型細分：全血球計數
  • 按類型細分：血液凝固檢驗
  • 按類型細分：血紅素檢測
  • 按類型細分：貧血診斷
  • 按類型細分：其他類型

第14章 即時血液學診斷市場：區域與國家分析

第15章 亞太市場

第16章 東南亞市場

第17章 西歐市場

第18章：東歐市場

第19章：北美市場

第20章：南美洲市場

第21章 中東市場

第22章：非洲市場

第23章：競爭格局與公司概況

  • Point Of Care Hematology Diagnostics Market Competitive Landscape And & Market Share 2024
  • 公司簡介
  • Danaher Corporation（HemoCue AB）（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • F. Hoffmann-La Roche Ltd.（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Abbott Laboratories（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Siemens Healthineers（Company Overview, Products and Services, Business Strategy, Financial Overview）
  • Sysmex Corporation（Company Overview, Products and Services, Business Strategy, Financial Overview）

第24章 其他大型企業和創新企業

  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（Company Overview, Products and Services）
  • Instrumentation Laboratory（Werfen）（Company Overview, Products and Services）
  • Nova Biomedical Corp.（Company Overview, Products and Services）
  • Chengdu Seamaty Technology Co. Ltd.（Company Overview, Products and Services）
  • Edan Instruments Inc.（Company Overview, Products and Services）
  • Drucker Diagnostics（Company Overview, Products and Services）
  • DIAGON Kft.（Company Overview, Products and Services）
  • Boule Diagnostics AB（Company Overview, Products and Services）
  • A Menarini Industrie Farmaceutiche Srl（Company Overview, Products and Services）
  • Transasia Bio-Medicals Ltd.（Company Overview, Products and Services）
  • Medsource Ozone Biomedicals Pvt. Ltd.（Company Overview, Products and Services）
  • EKF Diagnostics Holdings plc（Company Overview, Products and Services）
  • BioMedomics Inc.（Company Overview, Products and Services）
  • PixCell Medical Technologies Ltd.（Company Overview, Products and Services）
  • HORIBA Ltd.（Company Overview, Products and Services）

第25章：競爭標竿分析

第26章：競爭對手儀錶板

第27章 即時血液診斷市場－公司估值矩陣

  • 創新與品牌領導者
  • 品牌主導傳統主義者
  • 專注於利基市場或區域市場的公司
  • 新興創新者

第28章：預計進入市場的新創企業

第29章 重大併購

  • Mars Inc Acquired Heska Corporation

第30章 近期趨勢

  • 人工智慧驅動的Milab BCM提升了墨西哥的即時血液診斷水準。

第31章 機遇與策略

  • 2030年全球即時血液學診斷市場：提供新機會的國家
  • 2030年全球即時血液學診斷市場：蘊藏新機會的細分市場
  • 2030年全球即時血液學診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第32章 即時血液學診斷市場：結論與建議

  • 結論
  • 推薦

第33章附錄

簡介目錄
Product Code: ME4MPCHD01_O26Q1

Point of care hematology diagnostics refers to blood testing performed at or near the site of patient care using compact, portable analyzers, rather than in centralized laboratories. The primary purpose of POC hematology diagnostics is to enable rapid clinical decision-making by providing immediate test results, typically within minutes. This allows healthcare providers to quickly diagnose conditions such as anemia, infections, and other blood disorders, initiate timely treatment, and monitor patient status in real time.

The point of care hematology diagnostics market consists of sales by entities (organizations, sole traders and partnerships) of point of care hematology diagnostics encompass portable analyzers, handheld devices, cartridges and reagents designed to measure key hematological indicators such as red and white blood cell counts, hemoglobin levels, hematocrit, platelet counts and coagulation parameters.

The global point of care hematology diagnostics market was valued at $1,947.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 8.00%.

Growing Awareness And Screening Programs For Anemia And Blood-Related Conditions

During the historic period, the point of care hematology diagnostics market was driven by the shift towards growing awareness and screening programs for anemia and blood-related conditions. Awareness and screening programs for anemia and blood-related conditions are organized public health initiatives aimed at educating people about these disorders and systematically testing individuals to detect them early for timely diagnosis and treatment. Awareness and screening programs for anemia and blood-related conditions enhance the demand for point-of-care diagnostics by enabling early detection, increasing testing frequency, and driving the need for rapid, accessible, and decentralized blood testing solutions. For instance, in August 2025, according to the Ministry of Health and Family Welfare (MoHFW), India's premier agency is Under the National Sickle Cell Anemia Elimination Mission, the Indian Council of Medical Research has validated 30 point-of-care tests and 5 non-rapid diagnostic assays for SCD screening, with over 6 crore individuals screened across 17 tribal-dominated states as of July 2025. Therefore, the point of care hematology diagnostics market was driven by the shift towards growing awareness and screening programs for anemia and blood-related conditions during the historic period.

Biotechnology, Genomics And Precision Medicine

Major companies operating in the point of care hematology diagnostics market are increasingly integrating biotechnology, genomics, and precision medicine approaches to enhance the accuracy, speed, and clinical relevance of blood testing at decentralized care settings. This trend focuses on leveraging biological insights, including genetic predispositions, molecular blood signatures, immune response patterns, and patient-specific hematological variability, to improve interpretation of complete blood count (CBC) and related parameters. By combining advanced diagnostic technologies such as microfluidics, AI-driven blood cell morphology analysis, and digital pathology with precision medicine frameworks, companies can move beyond conventional static blood counts toward more context-aware and patient-specific hematology insights. This approach enables earlier disease detection, improved monitoring of conditions such as anemia, infections, and hematologic disorders, and better treatment decision-making at the point of care.

The global point of care hematology diagnostics market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 24.27% of the total market in 2024.

Point Of Care Hematology Diagnostics Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global point of care hematology diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for point of care hematology diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The point of care hematology diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider point of care hematology diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market
  • Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type into, by mode of prescription, by end user channel in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for point of care hematology diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type Into: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
  • 2) By Mode Of Prescription: Prescription-Based Product; Over-The-Counter Based Product.
  • 3) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
  • Companies Mentioned: Danaher Corporation (HemoCue AB); F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers; Sysmex Corporation
  • Countries: China; Germany; Japan; UK; France; India; USA; Canada; South Korea; Brazil; Australia; Russia; Spain; Italy; Indonesia; Taiwan
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; point of care hematology diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Point Of Care Hematology Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Type (Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis And Other Types)
  • 6.5 Market Segmentation By Mode Of Prescription (Prescription Based Product And Over-The-Counter Based Product)
  • 6.6 Market Segmentation By End User (Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers And Other End Users)

7 Point Of Care Hematology Diagnostics Market, Overview Of Key Products/Services

  • 7.1 Global Point Of Care Hematology Diagnostics Market Attractiveness Scoring And Analysis
    • 7.1.1 Overview Of Market Attractiveness Framework
    • 7.1.2 Quantitative Scoring Methodology
    • 7.1.3 Market Attractiveness Scoring And Interpretation
    • 7.1.4 Factor-Wise Evaluation
    • 7.1.5 Strategic Implications And Recommendations

8 Point Of Care Hematology Diagnostics Market, Supply Chain Analysis

  • 8.1 Overview of the Supply Chain and Ecosystem
  • 8.2 Resources
    • 8.2.1 List Of Key Raw Materials And Resource Providers
  • 8.3 Manufacturers
    • 8.3.1 List Of Manufacturers (Suppliers)
  • 8.4 Distribution
    • 8.4.1 List Of Major Distributors and Channel Partners
  • 8.5 End Users
    • 8.5.1 List Of Major End Users

9 Major Market Trends

  • 9.1 Key Technologies & Future Trends
    • 9.1.1 Biotechnology, Genomics And Precision Medicine
    • 9.1.2 Artificial Intelligence And Autonomous Intelligence
    • 9.1.3 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
    • 9.1.4 Digitalization, Cloud, Big Data And Cybersecurity
    • 9.1.5 Industry 4.0 And Intelligent Manufacturing
  • 9.2 Major Trends
    • 9.2.1 AI-Powered Portable Systems Revolutionize Rapid Blood Analysis For Faster Clinical Decisions
    • 9.2.2 Advancements In Compact In-Clinic Hematology Analyzers For Rapid And Decentralized Blood Testing
    • 9.2.3 Integration Of Multimodal Benchtop Analyzers Enabling Rapid Decentralized Blood Testing And Faster Clinical Decision-Making
    • 9.2.4 Advancements In AI-Enabled Cartridge-Based Blood Analysis For Rapid And Accurate On-Site Diagnostics
    • 9.2.5 Next-Generation Low-Volume Blood Testing Transforming Diagnostics

10 Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

  • 10.1 Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 10.1.1 Political
    • 10.1.2 Economic
    • 10.1.3 Social
    • 10.1.4 Technological
    • 10.1.5 Environmental
    • 10.1.6 Legal
  • 10.2 Analysis Of End User (B2B)
    • 10.2.1 Diagnostic Centers
    • 10.2.2 Hospitals
    • 10.2.3 Blood Banks
    • 10.2.4 Transfusion Centers
    • 10.2.5 Other End Users

11 Global Point Of Care Hematology Diagnostics Market Size And Growth Analysis

  • 11.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
    • 11.1.1 Market Drivers 2020 - 2025
    • 11.1.2 Market Restraints 2020 - 2025
  • 11.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 11.3 Forecast Growth Contributors/Factors
    • 11.3.1 Quantitative Growth Contributors
    • 11.3.2 Drivers
    • 11.3.3 Restraints

12 Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM) Analysis

  • 12.1 Definition And Scope of Total Addressable Market (TAM)
  • 12.2 Methodology And Assumptions
    • 12.2.1 Total Addressable Market for the Point Of Care Hematology Diagnostics Market - Business to Business (B2B)
    • 12.2.2 TAM Comparison Analysis

13 Global Point Of Care Hematology Diagnostics Market Segmentation

  • 13.1 Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.2 Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.3 Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.4 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.5 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8 Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 Point Of Care Hematology Diagnostics Market, Regional and Country Analysis

  • 14.1 Global Point Of Care Hematology Diagnostics Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.2 Global Point Of Care Hematology Diagnostics Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Asia-Pacific Market

  • 15.1 Asia-Pacific Market Summary
  • 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 15.3 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.4 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.5 Asia Pacific Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6 China Market
    • 15.6.1 China Market Summary
    • 15.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 15.6.3 China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.6.4 China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.6.5 China Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7 India Market
    • 15.7.1 India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.7.2 India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.7.3 India Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8 Japan Market
    • 15.8.1 Japan Market Summary
    • 15.8.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
    • 15.8.3 Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.8.4 Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.8.5 Japan Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9 Australia Market
    • 15.9.1 Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.9.2 Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.9.3 Australia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.10 South Korea Market
  • 15.11 South Korea Market Summary
    • 15.11.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
    • 15.11.2 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.11.3 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.11.4 South Korea Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.12 Taiwan Market
  • 15.13 Taiwan Market Summary
    • 15.13.1 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
    • 15.13.2 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.13.3 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 15.13.4 Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 South East Asia Market

  • 16.1 South East Asia Market Summary
  • 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 16.3 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.4 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.5 South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6 Indonesia Market
    • 16.6.1 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.6.2 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 16.6.3 Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Western Europe Market

  • 17.1 Western Europe Market Summary
  • 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.3 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.4 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.5 Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6 UK Market
    • 17.6.1 UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.6.2 UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.6.3 UK Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7 Germany Market
    • 17.7.1 Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.2 Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.7.3 Germany Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.8 France Market
    • 17.8.1 France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.8.2 France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.8.3 France Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.9 Italy Market
    • 17.9.1 Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.9.2 Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.9.3 Italy Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.10 Spain Market
    • 17.10.1 Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.10.2 Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 17.10.3 Spain Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Eastern Europe Market

  • 18.1 Eastern Europe Market Summary
  • 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 18.3 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.4 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.5 Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6 Russia Market
    • 18.6.1 Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.6.2 Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 18.6.3 Russia Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 North America Market

  • 19.1 North America Market Summary
  • 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 19.3 North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.4 North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.5 North America Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.6 USA Market
    • 19.6.1 USA Market Summary
    • 19.6.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
    • 19.6.3 USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.6.4 USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.6.5 USA Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 19.7 Canada Market
    • 19.7.1 Canada Market Summary
    • 19.7.2 Market Overview (Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
    • 19.7.3 Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.7.4 Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 19.7.5 Canada Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 South America Market

  • 20.1 South America Market Summary
  • 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 20.3 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.4 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.5 South Ameria Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 20.6 Brazil Market
    • 20.6.1 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 20.6.2 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
    • 20.6.3 Brazil Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Middle East Market

  • 21.1 Middle East Market Summary
  • 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 21.3 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.4 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 21.5 Middle East Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Africa Market

  • 22.1 Africa Market Summary
  • 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 22.3 Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.4 Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 22.5 Africa Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Competitive Landscape And Company Profiles

  • 23.1 Point Of Care Hematology Diagnostics Market Competitive Landscape And & Market Share 2024
    • 23.1.1 Top 10 Companies (Ranked by revenue/share)
  • 23.2 Company Profiles
  • 23.3 Danaher Corporation (HemoCue AB) (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.4 F. Hoffmann-La Roche Ltd. (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.5 Abbott Laboratories (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.6 Siemens Healthineers (Company Overview, Products and Services, Business Strategy, Financial Overview)
  • 23.7 Sysmex Corporation (Company Overview, Products and Services, Business Strategy, Financial Overview)

24 Other Major And Innovative Companies

  • 24.1 Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (Company Overview, Products and Services)
  • 24.2 Instrumentation Laboratory (Werfen) (Company Overview, Products and Services)
  • 24.3 Nova Biomedical Corp. (Company Overview, Products and Services)
  • 24.4 Chengdu Seamaty Technology Co. Ltd. (Company Overview, Products and Services)
  • 24.5 Edan Instruments Inc. (Company Overview, Products and Services)
  • 24.6 Drucker Diagnostics (Company Overview, Products and Services)
  • 24.7 DIAGON Kft. (Company Overview, Products and Services)
  • 24.8 Boule Diagnostics AB (Company Overview, Products and Services)
  • 24.9 A Menarini Industrie Farmaceutiche Srl (Company Overview, Products and Services)
  • 24.10 Transasia Bio-Medicals Ltd. (Company Overview, Products and Services)
  • 24.11 Medsource Ozone Biomedicals Pvt. Ltd. (Company Overview, Products and Services)
  • 24.12 EKF Diagnostics Holdings plc (Company Overview, Products and Services)
  • 24.13 BioMedomics Inc. (Company Overview, Products and Services)
  • 24.14 PixCell Medical Technologies Ltd. (Company Overview, Products and Services)
  • 24.15 HORIBA Ltd. (Company Overview, Products and Services)

25 Competitive Benchmarking

26 Competitive Dashboard

27 Point Of Care Hematology Diagnostics Market - Company Scoring Matrix

  • 27.1 Innovation & Brand Leaders
  • 27.2 Brand-Driven Traditionalists
  • 27.3 Niche or Regional Followers
  • 27.4 Emerging Innovators

28 Upcoming Startups In the Market

29 Key Mergers And Acquisitions

  • 29.1 Mars Inc Acquired Heska Corporation

30 Recent Developments

  • 30.1 AI-Driven Milab BCM Enhances Point-Of-Care Hematology Diagnostics In Mexico

31 Opportunities And Strategies

  • 31.1 Global Point Of Care Hematology Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 31.2 Global Point Of Care Hematology Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 31.3 Global Point Of Care Hematology Diagnostics Market In 2030 - Growth Strategies
    • 31.3.1 Market Trend Based Strategies
    • 31.3.2 Competitor Strategies

32 Point Of Care Hematology Diagnostics Market, Conclusions And Recommendations

  • 32.1 Conclusions
  • 32.2 Recommendations
    • 32.2.1 Product
    • 32.2.2 Place
    • 32.2.3 Price
    • 32.2.4 Promotion
    • 32.2.5 People

33 Appendix

  • 33.1 Geographies Covered
  • 33.2 Market Data Sources
  • 33.3 Research Methodology
  • 33.4 Currencies
  • 33.5 The Business Research Company
  • 33.6 Copyright and Disclaimer